Waste Management's Quiet Handoff: Healthcare Finally Pays, Landfills Get a Pricing Story, and the ERP Goes Silent
Jim Fish spent his final earnings call telling a story about being called a liar. In his first investor meeting as CFO, with SG&A at 12.7% of revenue, he promised Charles El-Wine of Capital World he could get it to 11%. “A couple years later, when we actually did get SG&A down to 11%, I will never forget. Charles called me, and he said, you know, Jim, I did not believe you at the time, but you did prove me wrong.” — James C. Fish Jr., Chief Executive Officer · 2026-10-28 The line lands because it is now 9.3%, and because the man telling it is retiring in early January after ten years as CEO, handing the job to President John Morris.
The handoff, and what the new CEO stops saying
The rotation itself is the biggest change in this report — and the tell is in what Morris chose to emphasise in his first remarks as CEO-designate. The company's keyword set this quarter is headed, for the first time in a year, by the Solid Waste business rather than healthcare. Morris made the sequencing explicit: with healthcare no longer absorbing management attention, “we have got the ability to be a little more aggressive in terms of what we do on the core solid waste side, and we see that as a strategic priority.” — John J. Morris Jr., President and Incoming Chief Executive Officer · 2026-10-28 WM has closed $239 million of tuck-ins through nine months, expects another $140 million in Q4, has signed a $250 million deal for early next year, and calls the pipeline robust into 2027.
The macro condition helping that is one the whole market is chewing on. Higher-for-longer rates are the dominant global theme of this quarter — banks everywhere are talking about impact of high rates and deposit costs. WM inverts it. David Reed noted close to 90% of interest rate exposure is fixed, so the company can be a buyer while smaller private haulers, contemplating a recap, face expensive funding. Higher rates, in other words, are a supply catalyst for WM's acquisition machine rather than a financing problem.
Healthcare: a two-year apology closes
The arc here is the most confirmable thing in the transcript, because the prior calls document the hole. A year ago, CFO Devina Rankin was promising “we expect to be through our stabilization period by the end of the first quarter.” — Devina Rankin, Executive Vice President and Chief Financial Officer · 2025-10-28 In January, Fish was setting low expectations for the acquired business: “we're expecting 4.2% price in 2026. Top line is going to be 3%, and that is a reflection of those lost accounts.” — James Fish, Chief Executive Officer · 2026-01-29 Through 2025 the dominant terminology was credit memos, deferred price increases, ERP, churn on the hospital side — all of which sat at or near the top of WM's own keyword rankings.
This quarter, healthcare revenue rose 3.7% — the first year-over-year increase since the acquisition — with operating EBITDA up 33%, core price at 5.5% and SG&A at 15.2% of revenue. Both targets management had set for year-end were hit in Q3. “For the first time since the acquisition, revenue was up year over year, and we grew operating EBITDA 33%... I believe this is going to prove to be 1 of the best acquisitions in the history of the company.” — James C. Fish Jr., Chief Executive Officer · 2026-10-28
What matters more than the print is the silence. The Healthcare business keyword fell out of the top of the company's own momentum table last quarter; this quarter the words ERP, credit memo and deferred price increase are effectively absent. The near term churn language that once dominated Q&A is replaced with improving sequential trends, and the synergy target is now expected around mid-2027, ahead of plan. The medical waste side still has negative volume — Morris declined to put "a stake in the ground" on when it inflects — but the profit engine no longer depends on that.
A $6.37 diesel print, a $63 million actuarial surprise, and the landfill lobby
The quarter's costs were where the real analyst friction sat. Diesel spiked to a record, and management referenced “$6.37 a gallon diesel” — John J. Morris Jr., President and Incoming Chief Executive Officer · 2026-10-28 while budgeting a roughly 40 basis point Q4 fuel headwind. This is not a WM problem alone — High fuel costs and Diesel fuel thread through reporters as disparate as JetBlue, Werner, Chefs' Warehouse and PACCAR this week. WM's answer is the surcharge mechanism, which covers indirect as well as direct fuel, with roughly a one-month billing lag as the only real slippage.
Less routine was risk management, a $63 million year-over-year increase — about $40 million in corporate and other, $23 million in collection and disposal — that cost roughly 40 basis points of margin and made an otherwise clean quarter look messy.
The first of which is we had a negative impact associated with our third quarter actuarial adjustment. It is always a little bit of a wild card, but I would point out that this follows 6 consecutive quarters of positive variances against our actuarial report.
The genuinely new theme is the cost side of the landfill. California legislation requiring enhanced monitoring, plus leachate handling, is lifting operating costs, and management expects it to persist — and to be recovered through price. This is where WM's structural position shows: with internalization rate at just over 72%, near record levels, and a next-best-alternative pricing model, cost inflation is a revenue event.
It is not just us. This is an industry wide issue, and so everyone is gonna be faced with some of these same issues across the board. So we are in a strong position, like I said, to deliver on price increase to recoup our costs.
Reed went further than the script: “as we look to 2027 and beyond, we are going to look to continue to enhance our landfill and transfer station pricing.” — David L. Reed, Executive Vice President and Chief Operating Officer · 2026-10-28 The Landfill operating costs theme is thus a 2027 pricing story in disguise, and one that sits adjacent to the broader regulatory drift captured globally as Policy reforms.
The cash machine, and the guidance asterisk
Mechanically, this remains a compounding cash business. Free cash flow exceeded $3 billion through nine months, up more than 42%, with EBITDA conversion above 50% and more than 90% of that cash returned to shareholders — $1.58 billion of buybacks and $1.14 billion of dividends. Leverage ended at 2.92x, inside the 2.5–3x target. Share repurchases alone hit $659 million in a single quarter, and free cash flow margin jumped to 15.7%, up 3.7 points year over year.
The offset is capital intensity. Capex fell 14% year over year as the sustainability build wrapped, and capex ran at roughly 9.4% of revenue against a stated long-run range of 10–10.5%. Meanwhile effective net cash sits at negative $21.6 billion — the acquisition's lasting balance-sheet signature.
Then the asterisk. Management guided revenue and free cash flow to the high end of ranges, but operating EBITDA only within the range. Noah Kaye did the arithmetic out loud: a sequentially higher but year-over-year-lower Q4 margin lands below the low end. Reed's answer — “that is just on the... 40 basis point impact of fuel, but I did highlight some of the items that depending on how they play out in the quarter will push us up higher in that range” — David L. Reed, Executive Vice President and Chief Operating Officer · 2026-10-28 — is honest but thin. After a year in which revenue growth has leaned on price and business formation has been soft in the commercial line, the fourth quarter is a fuel-and-volume coin flip.
The market has already discounted some of this. WM trades at 26.2x free cash flow, down 43% year over year, and the stock sits about 8.7% below its March peak, flat over three months. For a defensive compounder reporting a genuine operational turn in its most-watched problem business, with a new CEO who has not yet issued guidance, that gap between narrative and multiple is the thing worth watching into 2027.